Skip to main content
. 2010 Apr 19;588(Pt 12):2173–2191. doi: 10.1113/jphysiol.2010.190462

Figure 5. The relationship between PKB inhibition and the mitoKATP channel.

Figure 5

The mitoKATP channel inhibitor 5-HD (10 μm) was used to determine if the mitoKATP channel is upstream or downstream of PKB. For this, PKB inhibitor XI was encapsulated during 5-HD pre-treatment prior to ischaemia/reoxygenation (I/R) of rat left ventricular myocardial slices and compared to PKB inhibitor XI alone, as shown in A. For comparison, ischaemic preconditioning (IP) was also encapsulated during 5-HD administration prior to I/R. In all cases tissue samples were analysed for CK release during the 120 min reoxygenation (B), and for necrosis (C) and apoptosis (D) at the end of 120 min reoxygenation. Data represent the mean ±s.e.m. from 6 independent experiments. *P < 0.05 vs. I/R alone group; †P < 0.05 vs. IP group.